Status:

COMPLETED

Self-care Management Programme for Type 2 Adult DM Patients With Poor Glycemic Control

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Type 2 Diabetes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Type 2 diabetes becomes the most prevalence chronic disease worldwide. Most type 2 diabetes patient are under the care in public general out-patient clinic in Hong Kong. The chronic nature of diabetic...

Detailed Description

1. Safety Assessment There is no harmful effect from the intervention. 2. Statistics (A) Sample Size Estimation With reference from previous study (Aanand et al. 2011), the sample size is calc...

Eligibility Criteria

Inclusion

  • Aged \>=18
  • Clinically diagnosed of type 2 diabetes
  • Poorly glycemic control with recent HbA1c ≧ 7.5%
  • Chinese participants who could speak Cantonese

Exclusion

  • Unable to perform self-care management due to physical or mental limitation
  • Engage in another similar program
  • Pregnancy
  • Life expectancy \<1 year due to malignancies or other terminal illness

Key Trial Info

Start Date :

October 2 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2019

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04092023

Start Date

October 2 2018

End Date

September 1 2019

Last Update

September 18 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

KWC FM & PHC, Hospital Authority

Hong Kong, Hong Kong